CLO22-074: Patient-Reported Outcomes (PROs) in Patients (pts) With Advanced Non-Small Cell Lung Cancer (aNSCLC) With Programmed Cell Death-Ligand 1 (PD-L1) ≥50% Receiving Cemiplimab (CEMI) Monotherapy Versus Platinum-Doublet Chemotherapy (CHEMO): A Focus on the EMPOWER-Lung 1 Brain Metastases Subpopulation
| العنوان: | CLO22-074: Patient-Reported Outcomes (PROs) in Patients (pts) With Advanced Non-Small Cell Lung Cancer (aNSCLC) With Programmed Cell Death-Ligand 1 (PD-L1) ≥50% Receiving Cemiplimab (CEMI) Monotherapy Versus Platinum-Doublet Chemotherapy (CHEMO): A Focus on the EMPOWER-Lung 1 Brain Metastases Subpopulation |
|---|---|
| المؤلفون: | Mustafa Özgüroğlu, Ahmet Sezer, Saadettin Kilickap, Mahmut Gümüş, Igor Bondarenko, Miranda Gogishvili, Xuanyao He, Jennifer McGinniss, Giuseppe Gullo, Petra Rietschel, Ruben GW Quek |
| المصدر: | Journal of the National Comprehensive Cancer Network. 20:CLO22-074 |
| بيانات النشر: | Harborside Press, LLC, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Oncology |
| تدمد: | 1540-1413 1540-1405 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::0313b964c88aa28d3ccee60dc7eedc62 https://doi.org/10.6004/jnccn.2021.7246 |
| رقم الأكسشن: | edsair.doi...........0313b964c88aa28d3ccee60dc7eedc62 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15401413 15401405 |
|---|